24th week of 2011 patent applcation highlights part 45 |
Patent application number | Title | Published |
20110142916 | Adjuvants for Use in Vaccination - A compound of formula (I) for use as an adjuvant in vaccination; wherein R is an optionally-substituted alkyl, alkenyl, alkynyl, aryl, arylalkyl or alkylaryl moiety having from 1 to 50 carbon atoms; R | 2011-06-16 |
20110142917 | COMPOSITIONS AND METHODS FOR TREATMENT OF EAR DISORDERS - The present invention relates to pharmaceutical compositions useful for topical, non-invasive delivery of an oligonucleotide to the ear and to methods for the treatment of an ear disorder, including hearing loss arising from chemical-induced ototoxicity, acoustic trauma and presbycusis; and microbial infections. The method comprises topically administering to the ear of a subject in need thereof a pharmaceutical composition comprising an inhibitory oligonucleotide, a permeability enhancer and a pharmaceutically acceptable carrier, wherein the oligonucleotide reduces or inhibits expression of a gene associated with the ear disorder in the subject. | 2011-06-16 |
20110142918 | ANTI-ANGIOGENIC COMPOSITIONS AND THERAPEUTIC APPLICATIONS THEREOF - There is described the use of the Human herpesvirus type 6 (HHV-6) U94 gene and its product, the protein Rep, expression vectors and pharmaceutical compositions suitable for the delivery of the U94 gene or the protein encoded therefrom to the therapeutic sites, to inhibit angiogenic and lymphangiogenic processes in a subject in need thereof. | 2011-06-16 |
20110142919 | Cytotoxic T-Lymphocyte-Inducing Immunogens for Prevention, Treatment and Diagnosis of Cancer - The present invention relates to compositions and methods for the prevention, treatment, and diagnosis of cancer, especially carcinomas, such as ovarian carcinoma. The invention discloses peptides, polypeptides, and polynucleotides that can be used to stimulate a CTL response against cancer. | 2011-06-16 |
20110142920 | TREATMENT OF LENGTH DEPENDENT NEUROPATHY - Compositions, and methods of use thereof, are provided for the treatment of painful neuropathy by local or topical delivery of compounds that interact with α-adrenergic receptors, especially an alpha | 2011-06-16 |
20110142921 | NOVEL RNAi THERAPEUTIC FOR TREATMENT OF HEPATITIS C INFECTION - Small interfering RNAs (siRNAs) or small hairpin RNA (shRNAs) and compositions comprising same are provided that specifically target human cyclophilin A (CyPA) to effectively inhibit Hepatitis C (HCV) infection in a cell. Such siRNA and shRNAs may have a length of from about 19 to about 29 contiguous nucleotides corresponding to a specific region of human cyclophilin A (CyPA) cDNA of from about nucleotide 155 to about nucleotide 183 having particular potency against CyPA and HCV. Such siRNA and shRNAs may be formulated as naked compositions or as pharmaceutical compositions. DNA polynucleotides, plasmids, and viral or non-viral vectors are also provided that encode siRNA or shRNA molecules, which may be delivered directly to cells or in combination with known delivery agents, such as lipids, polymers, encapsulated lipid particles, such as liposomes. Methods for treating, managing inhibiting, preventing, etc., HCV infection using such siRNA and shRNAs and compositions comprising same are also provided. | 2011-06-16 |
20110142922 | STABILIZED COMPOSITION AND METHOD FOR DERMATOLOGICAL TREATMENT - A stabilized, topical composition for the treatment of acne and other dermatological conditions comprises a liposomal formulation of a retinoid and an antibiotic in which the retinoid is disposed in the lipid phase of the formulation, and the antibiotic is disposed in the aqueous phase so as to be isolated from the retinoid. Lincosamides, such as clindamycin, are one group of antibiotics which may be used in the composition. Tretinoin is one preferred retinoid. Also disclosed are methods for making the compositions and methods for using the composition. | 2011-06-16 |
20110142923 | OPHTHALMIC PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF NEOANGIOGENIC PATHOLOGIES OF THE EYE - The present invention relates to ophthalmic pharmaceutical compositions comprising Sorafenib, its derivatives or active metabolites, for the treatment and prevention of ocular neoangiogenic pathologies. | 2011-06-16 |
20110142924 | Irilis biopreparation based on bacillus-strain bacteria, bacillus subtilis and bacillus licheniformis contained therein - A bioengineering, in particular to develop novel probiotic preparations based on | 2011-06-16 |
20110142925 | Film Coating For Tablets And Caplets - The present invention relates to novel coating compositions for application to solid dosage forms such as tablets or caplets, solid dosage forms coated with the composition, and methods of preparing said coating compositions. | 2011-06-16 |
20110142926 | Nanoparticles for protein drug delivery - The invention discloses the nanoparticles composed of chitosan, poly-glutamic acid, and at least one antibiotics or equivalent bioactive agent characterized with a positive surface charge and their enhanced permeability in oral drug delivery. | 2011-06-16 |
20110142927 | Nanoparticles for protein drug delivery - The invention discloses the nanoparticles composed of chitosan, poly-glutamic acid, and at least one anti-hemophilic factor or bioactive agent characterized with a positive surface charge and their enhanced permeability in oral drug delivery. | 2011-06-16 |
20110142928 | PROCESS FOR THE PRODUCTION OF CALCIUM COMPOSITIONS IN A CONTINUOUS FLUID BED - The present invention discloses a process for producing a particulate material comprising a calcium-containing compound, the process comprises granulating and/or coating a powder mixture, which comprises the calcium-containing compound together with one or more pharmaceutically acceptable excipients in a continuous fluid bed apparatus. | 2011-06-16 |
20110142929 | SOLID PHARMACEUTICAL FORMULATIONS COMPRISING BIBW 2992 - The present invention relates to a pharmaceutical dosage form containing the active substance BIBW 2992 as the dimaleate salt, providing an immediate release profile of the active substance, further, the invention relates to compacted intermediates comprising BIBW 2992 dimaleate salt (BIBW 2992 MA | 2011-06-16 |
20110142930 | Pharmaceutical Compositions of Atorvastatin - A dry-granulated pharmaceutical composition comprising atorvastatin or a pharmaceutically acceptable salt thereof, as well as a dry-granulated pharmaceutical composition comprising atorvastatin or a pharmaceutically acceptable salt thereof in combination with at least one other active drug, methods for preparing said compositions, kits for containing such compositions, and a method of treating hypercholesterolemia and/or hyperlipidemia, osteoporosis, benign prostatic hyperplasia (BPH), and Alzheimer's disease using a therapeutically effective amount of the pharmaceutical composition. | 2011-06-16 |
20110142931 | SOFT TABLET CONTAINING DEXTROSE MONOHYDRATE - The invention relates to a tablet capable of being chewed or disintegrated in the oral cavity, which comprises a pharmaceutically active ingredient, and a matrix comprising directly compressible dextrose monohydrate and sucralose, said tablet being substantially fat free and said matrix being substantially free of non-saccharide, water soluble polymeric binders. | 2011-06-16 |
20110142932 | Pharmaceutical Tablets Comprising a Plurality of Segments - Deeply scored pharmaceutical tablets are disclosed, along with pharmaceutical tablets with a score in a segment that adjoins a segment lacking a pharmacologically effective dose of any drug. | 2011-06-16 |
20110142933 | Controlled Release Dosage Form of Tacrolimus - A controlled release dosage form of tacrolimus, comprising a solid dispersion of tacrolimus, wherein a controlled release base, which is selected from the group consisting of a water-soluble macromolecule, a gum base, and a membrane forming agent and does not form the solid dispersion of tacrolimus, is further contained, is disclosed. The controlled release dosage form of tacrolimus has an excellent controlled release and shows a stable blood concentration. | 2011-06-16 |
20110142934 | MUCOSOMAL ALLERGEN-SPECIFIC IMMUNOTHERAPY WITH INITIAL DOSING AFTER START OF POLLEN SEASON - The present invention relates to mucosal allergen-specific immunotherapy with a seasonal allergen, wherein the therapy is initiated after start of the pollen season of the seasonal allergen. Preferably, the seasonal allergen is provided in solid dosage form and is administered daily. Furthermore, advantageously, the same dose may be used throughout the treatment period since up-dosing is not required. | 2011-06-16 |
20110142935 | CARDIAC DIFFERENTIATION OF HUMAN PLURIPOTENT STEM CELLS UNDER DEFINED CONDITIONS USING MATRIX OVERLAY METHODS - Methods for culturing the pluripotent stem cells to undergo epithelial-to-mesenchymal transition and for generating high-yield, high-purity cardiomyocyte cultures from pluripotent stem cells are described. Pluripotent stem cells are cultured on a support with an overlaid matrix and, optionally, exposed to one or more factors to induce epithelial-to-mesenchymal transition and cardiogenesis. | 2011-06-16 |
20110142936 | IMPLANTS AND BIODEGRADABLE FIDUCIAL MARKERS - Implantable materials may be used in an iatrogenic site. Applications include radioopaque materials for fiducial marking. | 2011-06-16 |
20110142937 | Methods and Compositions To Treat Hemorrhagic Conditions of The Brain - The described invention provides a nonhuman animal model system for hemorrhagic brain conditions, methods for evaluating a substance for treating the hemorrhagic brain condition in a mammal, methods for treating hematoma expansion or recurrent rebleeding resulting from hemorrhagic brain conditions in a mammal, and pharmaceutical compositions for administration into or at a distance proximal to the hemorrhagic brain condition. | 2011-06-16 |
20110142938 | Nanotubes as Mitochondrial Uncouplers - A method of uncoupling mitochondria in a subject including administering nanotubes to the subject in a therapeutically effective amount, wherein the nanotubes are self-rectifying is provided. A method of decreasing reactive oxygen species and decreasing detrimental loading of Ca | 2011-06-16 |
20110142940 | Analgesic Apatitic Calcium-Phosphate Cement - The present invention concerns a composition useful as bone substitute comprising one or more calcium-phosphate compounds in association with an analgesic. It also refers to a preparation process of said composition, a preparation process of a drug-combined device comprising said composition, the drug combined device thus obtained, a kit comprising said composition and the use of said composition for the preparation of a drug-combined device useful for filling a bony defect caused in the iliac crest by collection of auto-graft bone, as a scaffold for tissue engineering and to produce a dental or bony implant. | 2011-06-16 |
20110142941 | Nanoparticle and Polymer Formulations for Thyroid Hormone Analogs, Antagonists, and Formulations and Uses Thereof - Disclosed are methods of treating subjects having conditions related to angiogenesis including administering an effective amount of a polymeric Nanoparticle form of thyroid hormone agonist, partial agonist or an antagonist thereof, to promote or inhibit angiogenesis in the subject. Compositions of the polymeric forms of thyroid hormone, or thyroid hormone analogs, are also disclosed. | 2011-06-16 |
20110142942 | USE OF pH SENSITIVE COMPOUNDS IN TASTE MASKING OF DRUG SUBSTANCES WITHIN ORAL THIN FILM STRIPS - The present invention relates to an edible film dosage form that includes a film-forming polymer and a coated active composition capable of taste-masking an active contained therein. An edible film that includes an edible, water-soluble film forming polymer and an active with at least two coating layers is also disclosed. | 2011-06-16 |
20110142943 | TAMPER-RESISTANT PHARMACEUTICAL COMPOSITIONS OF OPIODS AND OTHER DRUGS - Tamper-resistant pharmaceutical compositions have been developed to reduce the likelihood of improper administration of drugs, especially drugs such as opioids. The tamper-resistant compositions retard the release of drug, even if the physical integrity of the formulation is compromised (for example, by chopping with a blade or crushing) and the resulting material is placed in water, snorted, or swallowed. However, when administered as directed, the drug is slowly released from the composition as the composition is passes through the GI tract. | 2011-06-16 |
20110142944 | ANDROGRAPHIS EXTRACT FORMULATIONS - A pharmaceutical formulation containing 50-90% by weight a powdered extract of Andrographis paniculata and 5-50% by weight a powdered blocking agent. The formulation may further contain a pore-forming agent, a filler, a lubricant, or a glidant. Also described are a method for preparing this pharmaceutical formulation and a method for treating inflammatory disease, immunological disease, or respiratory disease with it. | 2011-06-16 |
20110142945 | Hydrophobic Active Agent Compositions and Related Methods - Compositions and methods for providing hydrophobic active agents in a bioavailable form are disclosed and described. In one aspect of the invention, pharmaceutical composition containing a testosterone ester is provided. The composition includes a testosterone ester in both dissolved form and as undissolved particles and the dissolved form comprises at least 35 wt % of the testosterone ester present in the composition. The composition further includes a solubilizer and a stabilizer. | 2011-06-16 |
20110142946 | DRUG SUSTAINED-RELEASE AGENT, ADSORBENT, FUNCTIONAL FOOD, MASK AND ADSORPTION SHEET - Provided is a drug sustained-release agent including a carbon material (porous carbon material) which has an inverse opal structure. The drug sustained-release agent includes a porous carbon material which has spherical pores having an average diameter of 1×10 | 2011-06-16 |
20110142947 | NOVEL FORMULATIONS - Nanoparticles comprising T3 and their use in treating, e.g., cardiac conditions, for example cardiac arrest, are provided. Such nanoparticles provide improved delivery of T3 and allow for acute treatment and optionally for sustained release of T3 in a patient. | 2011-06-16 |
20110142948 | Nanoparticle Carrier Systems based on Human Serum Albumin for Photodynamic Therapy - Compositions, which are stable in storage, and a method of production of pharmaceutical based nanoparticulate formulations for photodynamic therapy comprising a hydrophobic photosensitizer, human serum albumin (HSA) and stabilizing agent are provided. These nanoparticulate formulations provide therapeutically effective amounts of photosensitizer (PS) for parenteral administration. In particular, tetrapyrrole derivatives can be used as photosensitizers whose efficacy and safety are enhanced by such nanoparticulate formulations. A method of preparing the HSA-based nanoparticles under sterile conditions is also provided. In one of the preferred embodiments of the present invention temoporfin, a hydrophobic PS, is formulated as a nanoparticle for parenteral administration. The formulations are useful for treating hyperplasic and neoplasic conditions, inflammatory problems, and more specifically to target tumor cells. | 2011-06-16 |
20110142949 | CHONDROITINASE TREATMENT METHOD FOR DEMYELINATION-RELATED CONDITIONS AND DISEASES - A method of treating a mammal suffering from a demyelinating disease or condition, the method comprising administering chondroitinase to said mammal at a site where demyelination has occurred. | 2011-06-16 |
20110142950 | POLYMER MICELLES CONTAINING ANTHRACYLINES FOR THE TREATMENT OF CANCER - The present invention provides micelles having an anthracycline encapsulated therein, the micelles comprising a multiblock copolymer. The invention further provides methods of preparing and using said micelles, and compositions thereof. | 2011-06-16 |
20110142951 | MICELLES FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS - Composition comprising a polymeric micelle and an associated polynucleotide. | 2011-06-16 |
20110142952 | Pharmaceutical Compositions - This invention relates to crosslinked amine-containing polymers for binding compounds or ions, and more specifically relates to pharmaceutically acceptable compositions for binding compounds or ions that include crosslinked amine-containing polymers. The pharmaceutically acceptable composition includes, for example, crosslinked polyamine particles, or pharmaceutically acceptable salts thereof, having a particle size distribution wherein greater than 10 vol. % of the particles have a particle size greater than 500 μm. | 2011-06-16 |
20110142953 | COMBINATIONS OF IMMUNOSUPPRESSIVE AGENTS FOR THE TREATMENT OR PREVENTION OF GRAFT REJECTIONS - A pharmaceutical composition useful in the treatment or prevention of transgenic xenograft rejection comprising immunosuppressant compounds selected from the group consisting of an IL-2 transcription inhibitor and immunosuppressant compounds that immunosuppress for B-cell-mediated or antibody-mediated rejection of xenografts, and pharmaceutically acceptable diluents or carriers, and a method of preventing hyperacute rejection, reducing early graft damage, improving early xenograft function and promoting long term survival of said transgenic xenografts comprising the steps of i) contacting the body fluid removed from a human recipient with a xenoantigenic material which is bound to a biocompatible solid support, ii) reintroducing the treated body fluid into the recipient, and iii) treating the recipient with said pharmaceutical composition. | 2011-06-16 |
20110142954 | TOPICAL TREATMENT AND MANUFACTURING METHOD - A topical treatment for psoriasis, eczema and other disorders and conditions includes beeswax, coconut oil, shea butter and cocoa butter. Optional ingredients can also be included. A method of manufacturing the composition includes the steps of preheating and liquifying the beeswax, adding other ingredients, slowly stirring the resulting composition at an elevated temperature, and formulating finished treatment products, such as bars and lotions. | 2011-06-16 |
20110142955 | AGENT FOR AMELIORATING STRESS-INDUCED IMMUNE FUNCTION MODULATION - The present invention relates to an agent for ameliorating stress-induced immune function modulation which comprises royal jelly. In addition, the present invention provides an anti-stress agent, pharmaceutical, food or beverage, or food additive that contains royal jelly as an active ingredient thereof and prevents or alleviates various somatic symptoms caused by stress. | 2011-06-16 |
20110142956 | USE OF A PDE 5 INHIBITOR FOR TREATING AND PREVENTING HYPOPIGMENTARY DISORDERS - The invention relates to the use of PDE5 inhibitors for treating and/or preventing hypopigmentary disorders. | 2011-06-16 |
20110142957 | METHOD OF TREATING PARTURIENT PLACENTAL MAMMALS IN ORDER TO REDUCE MATERNAL AND/OR UTERINE EXHAUSTION - The present invention relates to a method of facilitating the birth process of placental mammals, especially to a method of reducing delays in the birth process and, thereby, complications resulting there from that may negatively affect the health and wellbeing of the mother and increase the incidence of stillbirths and/or neonatal mortality. According to the present invention delays in parturition that result from maternal and/or uterine exhaustion may be prevented or reduced by the administration of an effective amount of one or more psychomotor stimulants to the parturient mammal prior to and/or during parturition. Said psychomotor stimulant is selected from the group comprising xanthines and amphetamines. | 2011-06-16 |
20110142958 | COMPOSITION AND METHOD FOR CONTROL OF PLANT PATHOGENIC BACTERIA AND ENDOPHYTIC MICROORGANISMS USING COPPER PHOSPHITE AND NUTRIENT-HALO-PHOSPHITE COMPOUNDS - The present disclosure is directed toward a composition and method of treating and preventing infection of pathogenic microorganisms and endopyhtic microorganisms in a plant through the use of phosphite compositions. | 2011-06-16 |
20110142959 | METHODS, SYSTEMS AND COMPOSITIONS INVOLVED IN THE SYNTHESIS OF NONSTABLE COMPOUNDS - Systems, compositions, and methods for producing one or more unstable chemical species uniformly at an invariant rate of production over time and at substantially precise and/or exact concentrations are disclosed. The produced unstable product is synthesized from unstable chemical reactants. The present disclosure further describes methods of storage of an unstable chemical product to deliver it at a specific desired concentration at a specific time. | 2011-06-16 |
20110142960 | NUTRITIONAL SUPPLEMENT FOR OSTEOARTHRITIS - The present invention relates to a method of treating osteoarthritis by administering a mineral composition in the form of a nutritional supplement, where the mineral composition may contain Smectite, Gypsum, Quartz, Feldspar, Jarosite, Kaolinite and/or Zeolite. | 2011-06-16 |
20110142961 | METHODS AND REAGENTS FOR PREDICTING CLINICAL OUTCOME AND CUSTOMIZING CHEMOTHERAPY IN LUNG CANCER PATIENTS - The invention relates to methods for the prediction of the clinical outcome of a patient suffering from cancer based on the relative expression levels of BRCA1 and RAP80 genes. The invention also relates to anticancer combination therapies comprising a platinum-based chemotherapeutic agent and an inhibitor of RAP80. | 2011-06-16 |
20110142962 | Oral Rehydration Solutions Comprising Dextrose - The present disclosure is directed to oral rehydration solutions, and the use of these solutions to prevent dehydration due to fever. The oral rehydration solutions of the present disclosure may be oral rehydration solutions comprising about 12 mEq/L to about 18 mEq/L of sodium, from about 11 g/L to about 60 g/L of dextrose, a zinc source, and less than about 25 mEq/L of citrates. The pH of the oral rehydration solutions can be controlled by adjusting the amount of dextrose present in the oral rehydration solutions, allowing for formulation of oral rehydration solutions comprising lower levels of citrates. | 2011-06-16 |
20110142963 | Herbal medicinal composition and extract thereof for inhibiting growth of cancer cells - The present invention relates to herbal medicinal compositions and extracts thereof for inhibiting growth of cancer cells. One of the examples described in the present invention comprises Forsythiae fructus, Menthae Herba, Gardeniae Fructus, Scutellariae Radix, Lophatheri Folium, Glycyrrhizae Radix, Rhei Rhizoma, Na | 2011-06-16 |
20110142964 | Increasing athletic performance in humans with ruta chalepensis extract - The present invention relates to increasing the athletic performance of humans, using ruta chalepensis extract as an oral supplement or medicine. Use of the invention provides increased muscle strength, muscle power, endurance, muscle protein content, and/or reduced fatigue following exercise or competition. | 2011-06-16 |
20110142965 | SKIN MOISTURIZER AND WASHING FORMULATION - Disclosed is a liquid skin cleansing and moisturizing composition comprising a skin moisturizing agent, a cationic guar gum, an anionic surfactant, a zwitterionic surfactant, and a non-lipid structuring agent, wherein the composition is dermatologically acceptable and formulated as a rinse-off composition. | 2011-06-16 |
20110142966 | AQUEOUS EXTRACTS OF ANOECTOCHILUS SPP. KINSENOSIDE AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR HEPATOPROTECTION - A pharmaceutical composition useful for hepatoprotection is provided. The composition comprises an effective amount of kinsenoside or a pharmaceutically acceptable salt or ester thereof. An aqueous extract of | 2011-06-16 |
20110142967 | METHOD OF REDUCING BLOOD CHOLESTEROL AND TRIGLYCERIDE LEVELS USING COMBINATIONS OF VASOPROTECTIVE AGENT - Combinations of vasoprotective agents useful for the treatment of reducing blood cholesterol and triglyceride levels induced by an excess of plasma lipids. The agents include polycosanols, tocotriends and/or lycopene, procyanidole oligomers and vegetable oil rich in insaturated fatty acids. | 2011-06-16 |
20110142968 | Nutritional supplement - A nutritional supplement useful for promoting good overall health and relieving minor aches and pains associated with inflammation and muscle soreness includes a plurality of active herbal ingredients (turmeric extract, white willow extract, passion flower extract, valerian root extract, and/or licorice root extract), a plurality of non-herbal active ingredients (magnesium glycinate, vitamin B1 (thiamine HCI), vitamin B2 (riboflavin), vitamin B3 (niacinamide), vitamin B6 (pyridoxine HCI), folic acid, vitamin B12, and/or beta carotene). The nutritional supplement may be in the form of an effervescent tablet that is dissolvable in a potable liquid and can include one or more sweeteners and flavorings. | 2011-06-16 |
20110142969 | EXTRACT OF PIPER BETEL LEAVES FOR THE TREATMENT OF HUMAN MALIGNANCIES BY INDUCING OXIDATIVE STRESS - This invention relates to method of treating human malignancies of different origin that are sensitive to oxidative stress by administering effective amount of extract of | 2011-06-16 |
20110142970 | Multipurpose cleaner and method of cleaning using therapeutic grade essential oils - A multipurpose cleaning composition. The composition is a mixture of therapeutic grade essential oils, distilled white vinegar, and purified water that disinfects, degreases, and deodorizes, and also provides bioseptic and therapeutic benefits. Also provided is a method of disinfecting a surface by shaking a spray bottle having the composition, spraying the composition on the surface to be disinfected, allowing the composition to remain in contact with the surface for an amount of time sufficient to disinfect the surface, and removing the composition by wiping with a cloth. Essential oils may include, but are not limited to, therapeutic grade essential oils of eucalyptus, lemon, lavender, and grapefruit. | 2011-06-16 |
20110142971 | USE OF AN ONION EXTRACT FOR MAKING A COMPOSITION TO CONTROL WEIGHT GAIN - An onion extract weight gain control composition includes from 20% to 40% by weight of polyphenols belonging to the flavonol family, the onion extract having following composition characteristics, expressed in weight based on the dry extract total weight:
| 2011-06-16 |
20110142972 | COSMETIC COMPOSITION CONTAINING SALT-FERMENTED EXTRACT OF NATURAL MATERIALS - The present invention relates to a cosmetic composition containing a fermented extract of natural material. More specifically, the present invention discloses a cosmetic composition that contains either a salt-fermented extract of at least one of red bean, mung bean and black bean or a salt-fermented extract of a mixture obtained by adding deep-sea water to at least one of red bean, mung bean and black bean, and thus has antioxidant and anti-aging effects. | 2011-06-16 |
20110142973 | Compositions and methods for treating obesity, obesity related disorders and for inhibiting the infectivity of human immunodeficiency virus - The present invention relates to methods and pharmaceutical compositions for treating obesity or obesity-related disorders in a subject suffering from or predisposed to developing obesity or an obesity-related disorder, or for inhibiting the infectivity of HIV, by administering oleuropein, an analogue or derivative thereof, or the major metabolites of oleuropein including oleuropein aglycone, hydroxytyrosol, and elenolic acid or their analogues, or derivatives thereof, an iridoid glycoside, or a secoiridoid glycoside or analogues or derivatives thereof, or any combination of the foregoing including olive leave extract. The invention also relates to methods for screening/diagnosing a subject having, or predisposed to having obesity or a related disorder by measuring the expression profiles of an adipogenic gene selected from PPARγ2, LPL and αP2 gene and gene product, or other adipogenic, lipogenic, or lipolytic genes and gene products in an individual. The invention further provides for screening for novel oleuropein analogues. | 2011-06-16 |
20110142974 | TRIGONELLINE AS A MUSCLE STIMULANT - This invention relates to the use of trigonelline compounds to increase muscle weight during periods of activity or to inhibit muscle loss during periods of inactivity. | 2011-06-16 |
20110142975 | METHODS AND APPARATUS FOR PROCESSING MOLTEN MATERIALS - Various non-limiting embodiments disclosed herein relate to nozzle assemblies for conveying molten material, the nozzle assemblies comprising a body, which may be formed from a material having a melting temperature greater than the melting temperature of the molten material to be conveyed, and having a molten material passageway extending therethrough. The molten material passageway comprises an interior surface and a protective layer is adjacent at least a portion of the interior surface of the passageway. The protective layer may comprise a material that is essentially non-reactive with the molten material to be conveyed. Further, the nozzle assemblies according to various non-limiting embodiments disclosed herein may be heated, and may be self-inspecting. Methods and apparatus for conveying molten materials and/or atomizing molten materials using the nozzle assemblies disclosed herein are also provided. | 2011-06-16 |
20110142976 | VENTING DEVICE FOR MOLD - A mold blocking member is described for use in a vent bore of a mold for the manufacture of rubber products. The mold blocking member has a tubular hollow body having a first end and a second end. The second end is preferably chamfered for easy insertion into the mold. The first end has a spring element positioned thereon. A cap is affixed to a flat portion of the spring element. The bottom surface of the cap may optionally include channels. | 2011-06-16 |
20110142977 | Extended Life Tire Curing Bladder Composed of Aramid Fibers - Disclosed is a mixture to create expandable curing bladders for use in the curing process of rubber compositions such as tires. The bladders have an increased service with the addition of the aramid fibers to the rubber polymer. The aramid fibers increase the tear resistance of the cured product allowing for an increased number of expansions and contractions of the rubber polymer during the curing process. The use of these aramid fibers allows the tire curing bladders to cure more tires without changing out the bladder increasing the cost efficiency of the tire curing bladder. | 2011-06-16 |
20110142978 | DEVICE FOR FORMING TABLETS BY CONSTANT VOLUME COMPACTION - The invention relates to a press device for manufacturing tablets from a mixture of at least one component, comprising:
| 2011-06-16 |
20110142979 | PATTERNING APPARATUS - A patterning apparatus includes a stage arranged under a flexible substrate, a plurality of correction units arranged closely to the stage, attached to the flexible substrate, and configured to apply a tension force to the flexible substrate, and a pattern forming unit configured to form a pattern on the flexible substrate. The patterning apparatus corrects distortion of the flexible substrate by using the correction units. | 2011-06-16 |
20110142980 | DRIVE DEVICE FOR DRIVING A CLOSING PLATE IN A VERTICAL MOULD CASTING MACHINE AND MACHINE COMPRISING SAID DEVICE - The invention relates to a drive device for driving a closing plate in a vertical mould casting machine, the mentioned machine comprising displacement means for displacing the closing plate for compacting the casting and for extracting it from the machine. The displacement means comprise electric drive means and transmission means which are arranged between the mentioned electric drive means and the closing plate. The transmission means and the electric drive means are configured to transmit to the closing plate a first displacement with a first speed and a second displacement with a second speed greater than the first. | 2011-06-16 |
20110142981 | MOULDING UNIT FOR A PLANT FOR BLOW-MOULDING PLASTIC CONTAINERS, PARTICULARLY BOTTLES - A plant for blow-moulding plastic containers ( | 2011-06-16 |
20110142982 | INJECTION MOLDING MACHINE - A screw is moved along an axis by a screw advancement-retraction mechanism. A screw rotation mechanism is supported for movement along the axis by a pair of supporting members, each includes a rail for use as a guide member. The supporting members are arranged individually along tie-bars for use as lateral members and extend parallel to the tie-bars. One longitudinal end portion of each supporting member is secured to a frame of an injection unit by a fixing portion including a fixing member. The other end portion of the supporting member is supported on each tie-bar by a movable portion including a sliding member. The sliding member is movable along an axis of the tie-bar. With this arrangement, deformation, if any, of the tie-bar is prevented from affecting the rail, so that the screw rotation mechanism and the screw can move steadily. | 2011-06-16 |
20110142983 | AGENT FOR INHIBITING POSTPRANDIAL INCREASE IN BLOOD NEUTRAL FAT LEVEL AND FOODS CONTAINING THE SAME - The present invention herein provides an agent or a food for inhibiting a postprandial increase in blood neutral fat level. The agent or food comprises, as an effective component, a water-soluble and hardly digestible starch decomposed product having a content of hardly digestible components of at least 35% by mass. The water-soluble and hardly digestible starch decomposed product can be ingested separately or simultaneous with a high fat-content meal. | 2011-06-16 |
20110142984 | PASTA COMPOSITION FOR DEHYDRATED FOOD MATRICES - The present invention relates to a dry pasta composition comprising a combination of protein and fibres including beta-glucans which has a particularly satiating effect when rehydrated and consumed. A part of the protein is dairy protein. It is suitable for use in instant food products such as dehydrated soup and does not contain soy derivatives. The invention further relates to the use of beta-glucans in food compositions for inducing satiety and to a method of preparing satiety-inducing food compositions. | 2011-06-16 |
20110142985 | ADDITIVE FOR ANIMAL FEED AND METHOD FOR THE PREPARATION THEREOF - The invention relates to an additive intended in particular to promote feed uptake by animals such as piglets. This additive is in the form of granules each comprising at least one active plant extract and/or at least one flavouring incorporated into a matrix, each granule having a coating which comprises at least one sweetener and optionally at least one potentiator and at least one flavouring. The invention also relates to a method for preparing such an additive. | 2011-06-16 |
20110142986 | TRANSCONJUGANTS OF LACTIC ACID BACTERIA - The present invention relates to the field of dairy science. In particular, the present invention relates to methods for improving dairy starter culture quality as well as food products that can be obtained using such methods. | 2011-06-16 |
20110142987 | Use of proline specific endoproteases to hydrolyse peptides and proteins - The present invention relates to a process for the proteolytic hydrolysis of a peptide or a polypeptide, said peptide or polypeptide comprising 4 to 40, preferably 5 to 35, amino acid residues and said peptide or polypeptide is not hydrolysable by subtilisin whereby said peptide or polypeptide is hydrolysed by a proline specific endo protease at a pH of 6.5 or lower, preferably 5.5 or lower and more preferably 5.0 or lower to hydrolyse said peptide or polypeptide. | 2011-06-16 |
20110142988 | METHOD FOR PRODUCING DOUGH AND METHOD FOR PRODUCING BREAD - A method for producing dough includes a grinding process # | 2011-06-16 |
20110142989 | Hydrolysed Casein Product Comprising Tripeptides IPP and/or VPP - Process for the preparation of a hydrolysed casein product comprising tripeptides VPP, IPP and /or LPP, wherein a substrate comprising casein or casein fragments is subjected to enzyme treatment wherein the enzyme is derived from | 2011-06-16 |
20110142990 | POLYPHENOL - CONTAINING PRODUCTS - The invention relates to polyphenol-rich products of plants and also to a method of producing these products. In addition, the invention relates to the use of the polyphenol-containing products for producing foods, food supplements, dietetic foods and cosmetics; and also foods, food supplements, dietetic foods and cosmetics which contain such a product. | 2011-06-16 |
20110142991 | Method for treating feed silage for ruminants and feed silage additive - In a method for treating feed silage for ruminants, by which silage is mixed with a microorganism and the mixture of feed silage and microorganism is stored in a closed container for at least 30 days, it is provided that the feed silage is mixed with at least two microorganisms selected from the group consisting of | 2011-06-16 |
20110142992 | MEAT BASED FOOD PRODUCT - The present invention is related to a method for producing a meat based food product by treating meat with a phospholipase, to a meat based food product obtainable by the method of the invention and to use of a phospholipase for producing a meat based food product. | 2011-06-16 |
20110142993 | Method for Making Pet and Animal Comestibles - A method for making chew products for pets and domesticated animals includes selecting raw ingredients from animal and plant sources. Offal is separated from ingredients, which are then combined to form a base or base materials. The base materials are uniformly saturated with a digestive enzyme or a mixture of digestive enzymes. Saturated base materials are then dewatered and transformed into shapes. The shapes are dehydrated at a low temperature to retain enzyme activity and to render a shelf-stable product. | 2011-06-16 |
20110142994 | NOVEL STARCH COMPOSITION AND METHOD TO PRODUCE A BAKED PRODUCT - The invention relates to a novel starch composition comprising: (a) amylomaltase-treated starch; (b) amylopectin starch; and (c) optionally, low DE maltodextrin. In addition, the invention relates to the use of the novel starch composition to produce a baked product, optionally thereby reducing the amount of fat needed for the recipe. | 2011-06-16 |
20110142995 | COCONUT JUICE BEVERAGE WITH VITAMINS OR MINERALS OR BOTH - A beverage using coconut juice as a sole fluid base supplying water, fortified with one or more nutrients such as vitamins and minerals. The nutrient may be of a type which is insoluble in water, and has been artificially solubilized for compatibility with the fluid base. The beverage may be provided in concentrate form by removing some or all of the water present in natural coconut juice. The concentrate may be reconstituted by adding water obtained from a source other than the original coconut juice. The beverage or the concentrate may include non-nutritive components such as carbonation, sweeteners, preservatives, coloring agents, artificial flavors and fragrances. | 2011-06-16 |
20110142996 | PORTION CAPSULE AND USE OF A PORTION CAPSULE - A portion capsule for preparing a beverage is proposed, having a substantially frustoconical or cylindrical base element, which has a cavity for accommodating a beverage raw material, and a membrane which closes the cavity, with a wall region of the base element having a plurality of channels. | 2011-06-16 |
20110142997 | CLOSURE FOR DISPENSING PRESSURIZED OR CARBONATED BEVERAGE FROM A CONTAINER, CONTAINER USING SAID CLOSURE AND A SET COMPRISING SAID CONTAINER AND CLOSURE - Closure for a container for keeping pressurized or carbonated beverage, comprising means for dispensing the beverage from the container so that dispensation of gas not being dissolved in the beverage is prevented or reduced until all beverage has been dispensed, and being provided with means for permitting, preventing and optionally regulating dispensation of the beverage. Set comprising a container for keeping pressurized or carbonated beverage and a closure as disclosed above. Preferably the container is a standardized PET bottle. Preferably the beverage is a carbonated beverage, such as mineral water or soda or beer or sparkling wine or champagne. | 2011-06-16 |
20110142998 | SYSTEM AND METHOD FOR OPERATING ROTISSERIE OVEN - An oven for performing a rotisserie cooking operation includes an oven cavity having a door for selectively accessing the oven cavity, at least one heating element for heating the oven cavity and a rotisserie arm adapted to support a food product within the oven cavity. A motor is operatively coupled to the rotisserie arm for rotating the rotisserie arm and a food product. The oven also includes a control interface having a rotisserie cooking mode input and a control system for controlling the rotisserie motor and the heating element. In addition to other functions, the control system automatically causes the rotisserie motor to cycle on and off to allow for intermittent rotation of the food product supported on the rotisserie arm when the oven door is opened. | 2011-06-16 |
20110142999 | BATTER AND METHOD FOR PREPARING A PASTA - This invention describes a batter that is suitable for preparing a pasta. The batter comprises water, a starch and a protein, whereby the weight ratio between the protein and the total amount of starch in the batter is represented by the symbol y and whereby the weight percentage of the total amount of starch, with respect to the weight of the batter, is represented by the symbol x; whereby the following applies at the same time: | 2011-06-16 |
20110143000 | Photonic wine processor - An apparatus and method for modifying the organoleptic properties of a beverage, such as wine in a bottle, said apparatus having a least one light-source, said light-source applying peak wavelengths at intensities and time durations optimal for modifying said beverage's organoleptic properties. | 2011-06-16 |
20110143001 | DATE KERNEL PREPARATION - Provided is a preparation including a roasted date kernel blend and at least one thickener, a beverage thereof, a process for the production thereof and a process for producing the beverage. | 2011-06-16 |
20110143002 | METHOD OF APPLICATION OF BODY TASTE ENHANCER COMPRISING LONG-CHAIN HIGHLY UNSATURATED FATTY ACID AND/OR ITS ESTER - The purpose of the invention is to enhance the body taste, taste and flavor of foods. | 2011-06-16 |
20110143003 | NON-POROUS MOISTURE AND GAS PERMEABLE FILMS - A film comprises or is produced from a composition comprising a blend of a polyamide and an organic acid modified ionomer having its acid moiety at least partially neutralized to salts containing a majority of alkali metal ions, and the composition optionally comprises a compatibilizer selected from dicarboxylate-containing polymers, softened ethylene acid copolymers, ethylene glycidyl ester copolymers, or combinations of two or more thereof. | 2011-06-16 |
20110143004 | MATURATION OR RIPENING INHIBITOR RELEASE FROM POLYMER, FIBER, FILM, SHEET OR PACKAGING - Thermoplastic polyolefin polymer compositions, polymer chips, fibers, woven or nonwoven fabrics, films, closures, and laminates include a polymer and cyclodextrin compound with a volatile maturation inhibitor or an olefinic ethylene receptor antagonist in respiring produce materials. The polymer composition can also include a cyclodextrin-modified polymer or a substituted cyclodextrin. Olefinic ethylene inhibitors can be formed in the cyclodextrin composition, wherein the cyclodextrin releases the olefinic inhibitor composition when used in produce packaging materials. Coating compositions can also be made. The inhibitor is introduced into the materials and is released under controlled conditions of humidity. Upon release, the olefinic inhibitor blocks ethylene receptor sites on proteins that control maturation and can produce an extended period during which the produce does not substantially complete maturation or ripening to a degree leading to spoilage. | 2011-06-16 |
20110143005 | Methods for the Application of Ingredients to the Inside of a Straw - Methods of coating the interior surface of a hollow tubular structure, in particular a drinking device, and more particularly a drinking straw, with an edible composition to impart a desirable modification to a beverage that is drunk through the straw. The edible composition comprises an adhering agent and a powdered ingredient coated to the interior surface. Suitable adhering agents include lipids (e.g., soybean oil, corn oil, canola oil, sunflower oil, rapeseed oil, peanut oil, and mixtures thereof), medium chain triglycerides oils, emulsifiers, and mixtures thereof. Suitable powdered ingredients include edible acids, edible bases, sweeteners, flavorings, vitamins, minerals, colorants, sensate agents, carotenoids, antioxidants, polyphenols, phytonutrients, and mixtures thereof. The adhering agent is applied to the interior surface of the straw by any one of a number of methods followed by incorporating the powdered ingredient into the adhering agent layer. The powdered ingredient adheres or sticks to, and is incorporated into, the adhering agent layer. Once the powdered ingredient layer is added, the coated drinking straw is ready for use with a beverage. | 2011-06-16 |
20110143006 | DEVICE AND METHOD FOR FROTHING A LIQUID - A device for producing froth comprises means ( | 2011-06-16 |
20110143007 | NEW POLYDEXTROSE MATERIAL - The present invention discloses a new type of water-soluble polydextrose. This new type of polydextrose contains at least 75% by weight of saccharide molecules having a degree of polymerisation (DP) of 5 or more and characterised in that the non-digestible fiber content is at least 80% by weight. Further, the present invention relates to a process for preparing this new type of polydextrose and to the use of this polydextrose in products such as food products, pharmaceutical products and personal care products. | 2011-06-16 |
20110143008 | Frozen Slush Drink - A new formulation for frozen slush, flavored drinks is presented. A formulation has been found that will allow the formulation of tea, herbs or other plant extract based frozen slush drinks. The formulation is stable to freezing and thawing. The drink may be locally made and immediately consumed and also may be made using centralized controlled manufacturing and distribution of the finished product. A manufacturing process is also provided. | 2011-06-16 |
20110143009 | Stabilizers and Compositions and Products Comprising the Same - Compositions comprising microcrystalline cellulose, cellulose ether, and salt are provided together with methods for making them. Additionally, there are also described edible food products and industrial suspensions formed from these compositions. | 2011-06-16 |
20110143010 | STABILISED PARTICLES IN AN ALCOHOLIC BEVERAGE - The invention relates to an alcoholic beverage containing between 15 and 150 g/l of a particulate nut material, wherein the nut material has a particle size, preferably bimodal, between 0.05 and 200 ?m and the beverage contains 5 between 0.2 and 1.0 wt. % of a stabiliser comprising microcrystalline cellulose and optionally a soluble and/or anionic polysaccharide such as CMC. | 2011-06-16 |
20110143011 | GRANOLA CEREAL AND METHODS OF MAKING THE SAME - A method of making a cereal product in one embodiment includes mixing at least the following ingredients together to form a primarily granular mixture: between about 50% and about 90% oats, a non-sugar sweetener present in a volumetric ratio of from about 1:1000 to about 1:3000, between about 1% and about 10% ground flaxseed meal, between about 1% and about 7% olive oil, and between 0% and about 3% salt. The method further includes spreading the mixture on a cooking surface; baking the mixture on the cooking surface until the mixture is toasted; and disrupting the mixture at least once during the baking. Various embodiments of a baked cereal product are also disclosed. | 2011-06-16 |
20110143012 | METHODS OF ALGAE HARVESTING UTILIZING A FILTERING SUBSTANCE AND USES THEREFOR - Methods of harvesting algae, and using algae as a biofuel, livestock feed, or food supplement are provided. The methods comprise contacting liquid algae suspensions with a filtration media. Depending upon the filtration media, the resulting algae and filtration media admixture is then utilized as a biofuel, livestock feed, food supplements, or for the extraction of algae oil. Admixtures comprising a combustible filtration media, such as coal, are particularly preferred. The methods are suitable for use with any algae species. Compositions for use as a biofuel, livestock feed, or food supplement are also provided. These compositions comprise an admixture of algae and a filtration media. | 2011-06-16 |
20110143013 | ZEIN COMPOSITION AND METHODS OF PRODUCTION - A high cysteine content zein composition is provided. A method and system for the manufacture of the bioproduct is likewise disclosed herein. | 2011-06-16 |
20110143014 | COATINGS WITH TUNABLE MOLECULAR ARCHITECTURE FOR DRUG-COATED BALLOON - A drug delivery balloon is provided, the a balloon having an outer surface, and a tunable coating disposed on at least a length of the balloon surface. The tunable coating includes a first therapeutic agent and a first excipient, and can include a second therapeutic agent and a second excipient. The first and second therapeutic agents have different dissolution rates during balloon inflation and therefore provide a coating that is tunable. | 2011-06-16 |
20110143015 | PRIMER COMPOSITION FOR METAL OXIDE CERAMICS - [Problems] A primer used for pre-treating the surfaces of a prosthetic, which exhibits a large adhering force at the time of adhering a prosthetic of metal oxide ceramics to an object to be joined by using an adhesive such as a dental cement, the large adhering force being maintained for extended periods of time even in a severe environment such as in an oral cavity. | 2011-06-16 |
20110143016 | TEMPERATURE CONTROL METHOD FOR CHEMICAL VAPOR DEPOSITION APPARATUS - Provided is a method in which a difference between a surface temperature of a susceptor and a surface temperature of a substrate is accurately grasped without using a complicated high-priced equipment. A temperature control method for a chemical vapor deposition apparatus includes detecting a rotation state of a susceptor on which a substrate is accumulated on a top surface thereof, measuring a temperature of the top surface of the susceptor, calculating a temperature distribution of the top surface of the susceptor, based on the detected rotation state and the measured temperature, and controlling the temperature of the top surface of the susceptor, based on the calculated temperature distribution. | 2011-06-16 |